An integrated study of fibrinogen during blood coagulation

被引:105
作者
Brummel, KE [1 ]
Butenas, S [1 ]
Mann, KG [1 ]
机构
[1] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA
关键词
D O I
10.1074/jbc.274.32.22862
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The rate of conversion of fibrinogen (Fg) to the insoluble product fibrin (Fn) is a key factor in hemostasis. We have developed methods to quantitate fibrinopeptides (FPs) and soluble and insoluble Fg/Fn products during the tissue factor induced clotting of whole blood. Significant FPA generation (> 50%) occurs prior to visible clotting (4 +/- 0.2 min) coincident with factor XIII activation. At this time Fg is mostly in solution along with high molecular weight cross-linked products. Cross-linking of gamma-chains is virtually complete (5 min) prior to the release of FPB, a process that does not occur until after clot formation. FPB is detected still attached to the beta-chain throughout the time course demonstrating release of only low levels of FPB from the clot. After release of FPB a carboxypeptidase-B-like enzyme removes the carboxyl-terminal arginine resulting exclusively in des-Arg FPB by the 20-min time point. This process is inhibited by epsilon-aminocaproic acid. These results demonstrate that transglutaminase and carboxypeptidase enzymes are activated simultaneously with Fn formation. The initial clot is a composite of Fn I and Bg already displaying gamma-gamma cross-linking prior to the formation of Fn II with BP-chain remaining mostly intact followed by the selective degradation of FPB to des-Arg FPB.
引用
收藏
页码:22862 / 22870
页数:9
相关论文
共 66 条
[1]   PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR [J].
BAJZAR, L ;
MANUEL, R ;
NESHEIM, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14477-14484
[2]   The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent [J].
Bajzar, L ;
Nesheim, ME ;
Tracy, PB .
BLOOD, 1996, 88 (06) :2093-2100
[3]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF VASOACTIVE PEPTIDES DERIVED FROM FIBRIN OR FIBRINOGEN DEGRADED BY PLASMIN [J].
BELEW, M ;
GERDIN, B ;
LINDEBERG, G ;
PORATH, J ;
SALDEEN, T ;
WALLIN, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 621 (02) :169-178
[4]   CHARACTERIZATION OF PURIFIED RECOMBINANT FIBRINOGEN - PARTIAL PHOSPHORYLATION OF FIBRINOPEPTIDE-A [J].
BINNIE, CG ;
HETTASCH, JM ;
STRICKLAND, E ;
LORD, ST .
BIOCHEMISTRY, 1993, 32 (01) :107-113
[5]   2-STEP FIBRINOGEN-FIBRIN TRANSITION IN BLOOD-COAGULATION [J].
BLOMBACK, B ;
HESSEL, B ;
HOGG, D ;
THERKILDSEN, L .
NATURE, 1978, 275 (5680) :501-505
[6]   Fibrinogen and fibrin-proteins with complex roles in hemostasis and thrombosis [J].
Blomback, B .
THROMBOSIS RESEARCH, 1996, 83 (01) :1-75
[7]   HUMAN FIBRINOPEPTIDES ISOLATION CHARACTERIZATION AND STRUCTURE [J].
BLOMBACK, B ;
BLOMBACK, M ;
EDMAN, P ;
HESSEL, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1966, 115 (02) :371-&
[8]   Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties [J].
Boffa, MB ;
Wang, W ;
Bajzar, L ;
Nesheim, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2127-2135
[9]   Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma [J].
Broze, GJ ;
Higuchi, DA .
BLOOD, 1996, 88 (10) :3815-3823
[10]   Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases [J].
Butenas, S ;
vantVeer, C ;
Mann, KG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) :21527-21533